References
- Nielsen B, Cejvanovic V, Wortwein G, et al. Increased oxidation of RNA despite reduced mitochondrial respiration after chronic electroconvulsive stimulation of rat brain tissue. Neurosci Lett. 2019;690:1–5.
- Postal M, Appenzeller S. The importance of cytokines and autoantibodies in depression. Autoimmun Rev. 2015;14(1):30–35.
- Brundin L, Achtyes E. Has the time come to treat depression with anti-inflammatory medication? Acta Psychiatr Scand. 2019;139(5):401–403.
- Morrison FG, Miller MW, Wolf EJ, et al. Reduced interleukin 1A gene expression in the dorsolateral prefrontal cortex of individuals with PTSD and depression. Neurosci Lett. 2019;692:204–209.
- Yang XD, Yang YY, Ouyang DS, et al. A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia. 2015;100:208–220.
- Song W, Guo Y, Jiang S, et al. Antidepressant effects of the ginsenoside metabolite compound K, assessed by behavioral despair test and chronic unpredictable mild stress model. Neurochem Res. 2018;43(7):1371–1382.
- Song W, Wei L, Du Y, et al. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-kappaB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice. Int Immunopharmacol. 2018;63:227–238.
- Gonzalez-Parra S, Dauden E. Psoriasis and depression: the role of inflammation. Actas Dermosifiliogr. 2019;110(1):12–19.
- Felger JC. Role of inflammation in depression and treatment implications. Handb Exp Pharmacol. 2019;250:255–286.
- Irwin MR, Piber D. Insomnia and inflammation: a two hit model of depression risk and prevention. World Psychiatry. 2018;17(3):359–361.
- Palta P, Samuel LJ, Miller ER, 3rd, et al. Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med. 2014;76(1):12–19.
- Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995;41(12 Pt 2):1819–1828.
- Ogłodek EA, Just MJ. The association between inflammatory markers (iNOS, HO-1, IL-33, MIP-1β) and depression with and without posttraumatic stress disorder. Pharmacol Rep. 2018;70(6):1065–1072.
- Maes M, De Vos N, Pioli R, et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord. 2000;58(3):241–246.
- Park JS, Park EM, Kim DH, et al. Anti-inflammatory mechanism of ginseng saponins in activated microglia. J Neuroimmunol. 2009;209(1–2):40–49.
- Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012;379(9820):1045–1055.
- Lu M, Yang JZ, Geng F, et al. Iptakalim confers an antidepressant effect in a chronic mild stress model of depression through regulating neuro-inflammation and neurogenesis. Int J Neuropsychopharm. 2014;17(09):1501–1510.
- Park JS, Shin JA, Jung JS, et al. Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice. J Pharmacol Exp Ther. 2012;341(1):59–67.
- Xiao Y, Xu W, Su W. NLRP3 inflammasome: a likely target for the treatment of allergic diseases. Clin Exp Allergy. 2018;48(9):1080–1091.